BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klenerman P, Gupta PK. Hepatitis C virus: current concepts and future challenges. QJM 2012;105:29-32. [PMID: 22123990 DOI: 10.1093/qjmed/hcr231] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Yap JE, Jaiswal P, Ton L, Szynkarek R, Attar BM, Gandhi S. Successful treatment of chronic hepatitis C infection with crushed elbasvir/grazoprevir administered via a percutaneous endoscopic gastrostomy tube. J Clin Pharm Ther 2018;43:730-2. [DOI: 10.1111/jcpt.12713] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
2 Andrighetto LV, Dos Santos JS, Nicoletti G, Bock PM. INFLUÊNCIA DA VITAMINA D ASSOCIADA AO INTERFERON ALFA PEGUILADO E RIBAVIRINA NA RESPOSTA VIROLOGICA SUSTENTADA NA HEPATITE C CRÔNICA. Infarma 2016;28:140-148. [DOI: 10.14450/2318-9312.v28.e3.a2016.pp140-148] [Reference Citation Analysis]
3 Klenerman P, Fitzmaurice K. An update on hepatitis C virus. Clin Med (Lond) 2015;15 Suppl 6:s33-6. [PMID: 26634679 DOI: 10.7861/clinmedicine.15-6-s33] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Bell AM, Wagner JL, Barber KE, Stover KR. Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C. Int J Hepatol. 2016;2016:3852126. [PMID: 27403342 DOI: 10.1155/2016/3852126] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kim H, Meyer K, Di Bisceglie AM, Ray R. Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components. PLoS One 2014;9:e101422. [PMID: 24983375 DOI: 10.1371/journal.pone.0101422] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
6 Ehrenberg AE, Schmuck B, Anwar MI, Gustafsson SS, Stenberg G, Danielson UH. Accounting for strain variations and resistance mutations in the characterization of hepatitis C NS3 protease inhibitors. J Enzyme Inhib Med Chem. 2014;29:868-876. [PMID: 24517372 DOI: 10.3109/14756366.2013.864651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
7 Carobene M, Bolcic F, Farías MS, Quarleri J, Avila MM. HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina. J Med Virol 2014;86:64-70. [PMID: 24123155 DOI: 10.1002/jmv.23805] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
8 Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M. Association between vitamin D and hepatitis C virus infection: A meta-analysis. World J Gastroenterol 2013; 19(35): 5917-5924 [PMID: 24124339 DOI: 10.3748/wjg.v19.i35.5917] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
9 Iwami S, Koizumi Y, Ikeda H, Kakizoe Y. Quantification of viral infection dynamics in animal experiments. Front Microbiol 2013;4:264. [PMID: 24058361 DOI: 10.3389/fmicb.2013.00264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Brown J, McPherson A, Benson G. An overview and evaluation of combining an addiction liaison nurse outpatient service with hepatitis C outpatient clinics in Glasgow, Scotland. Gastroenterol Nurs 2013;36:98-104. [PMID: 23549212 DOI: 10.1097/SGA.0b013e3182895add] [Reference Citation Analysis]
11 Kim H, Meyer K, Di Bisceglie AM, Ray R. Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function. J Virol. 2013;87:5858-5867. [PMID: 23487461 DOI: 10.1128/jvi.00174-13] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
12 McCarthy M, Ortega MR. Neurological complications of hepatitis C infection. Curr Neurol Neurosci Rep 2012;12:642-54. [PMID: 22991069 DOI: 10.1007/s11910-012-0311-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Elsharkawy AM, Hudson M. The future developments in hepatology: no need for a jaundiced view. Frontline Gastroenterol 2012;3:i47-52. [PMID: 28839693 DOI: 10.1136/flgastro-2012-100153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]